Repair of bone defects with gelatin-based composites: A review

BioMedicine (Netherlands)

Volumn 1, Issue 1, 2011, Pages 29-32

  Chen, Kuo Yu ^a   Yao, Chun Hsu ^b  

^a NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bone tissue engineering; Composites; Gelatin

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE; CHI LI SAAN; CHINESE DRUG; CROSS LINKING REAGENT; GELATIN; GENIPIN; GU SUI BU; PROANTHOCYANIDIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; BONE CELL; BONE DEFECT; BONE MARROW CELL; BONE REGENERATION; CELL PROLIFERATION; CHINESE MEDICINE; COMPOSITE MATERIAL; FRACTURE HEALING; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; REVIEW; STROMA CELL; TISSUE ENGINEERING;

EID: 84861192498     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2011.10.005     Document Type: Review

References (33)

1. Qiu H., Yang J., Kodali P., Koh J., Ameer G.A. A citric acid-based hydroxyapatite composite for orthopedic implants. Biomaterials 2006, 27:5845-5854.
2. ®) in human bones. Biomaterials 2006, 27:1542-1549.
3. Vitale-Brovarone C., Verné E., Robiglio L., Appendino P., Bassi F., Martinasso G., et al. Development of glass-ceramic scaffolds for bone tissue engineering: characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater 2007, 3:199-208.
4. Bigi A., Bracci B., Panzavolta S. Effect of added gelatin on the properties of calcium phosphate cement. Biomaterials 2004, 25:2893-2899.
5. Gilding D.K. Biodegradable polymers. Biocompatibility of clinical implant materials 1981, vol. II.:209-232. CRC Press, Boca Raton, FL. D.F. Williams (Ed.).
6. Yao C.H., Sung J.S., Lin F.H., Liaw J.R., Huang C.W. Biological effects and cytotoxicity of tricalcium phosphate and formaldehyde cross-linked gelatin composite. Mater Chem Phys 1996, 45:6-14.
7. Lin F.H., Yao C.H., Sung J.S., Liu H.C., Huang C.W. Biological effects and cytotoxicity of the composite composed by tricalcium phosphate and glutaraldehyde cross-linked gelatin. Biomaterials 1998, 19:905-917.
8. Sung H.W., Huang D.M., Chang W.H., Huang R.N., Hsu J.C. Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: in vitro study. J Biomed Mater Res 1999, 46:520-530.
9. Liu H.C., Yao C.H., Sun J.S., Lee C.J., Huang C.W., Lin F.H. Osteogenic evaluation of glutaraldehyde crosslinked gelatin composite with fetal rat calvarial culture model. Artif Organs 2001, 25:644-654.
10. Bruder S.P., Jaiswal N., Ricalton N.S., Mosca J.D., Kraus K.H., Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Rel Res 1998, 355:S247-S256.
11. Mankani M.H., Kuznetsov S.A., Shannon B., Nalla R.K., Ritchie R.O., Qin Y., et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 2006, 168:542-550.
12. Yoshii T., Sotome S., Torigoe I., Tsuchiya A., Maehara H., Ichinose S., et al. Fresh bone marrow introduction into porous scaffolds using a simple low-pressure loading method for effective osteogenesis in a rabbit model. J Orthop Res 2009, 27:1-7.
13. Wang C., Wang Z., Li A., Bai F., Lu J., Xu S., et al. Repair of segmental bone-defect of goat's tibia using a dynamic perfusion culture tissue engineering bone. J Biomed Mater Res A 2010, 92:1145-1153.
14. Takahashi Y., Yamamoto M., Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and β-tricalcium phosphate. Biomaterials 2005, 26:3587-3596.
15. Bernhardt A., Despang F., Lode A., Demmler A., Hanke T., Gelinsky M. Proliferation and osteogenic differentiation of human bone marrow stromal cells on alginate-gelatin- hydroxyapatite scaffolds with anisotropic pore structure. J Tissue Eng Regen Med 2009, 3:54-62.
16. Rim N.G., Lee J.H., Jeong S.I., Lee B.K., Kim C.H., Shin H. Modulation of osteogenic differentiation of human mesenchymal stem cells by poly[(L-lactide)-co- (ε-caprolactone)]/gelatin nanofibers. Macromol Biosci 2009, 9:795-804.
17. Yao C.H., Liu B.S., Chang C.J., Hsu S.H., Chen Y.S. Preparation of networks of gelatin and genipin as degradable biomaterials. Mater Chem Phys 2004, 83:204-208.
18. Liu B.S., Yao C.H., Chen Y.S., Hsu S.H. In vitro evaluation of degradation and cytotoxocoty of a novel composite as a bone substitute. J Biomed Mater Res A 2003, 67:1163-1169.
19. Liu B.S., Yao C.H., Chen Y.S., Hsu S.H. Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin. J Biomed Mater Res A 2004, 69:709-717.
20. Bravol L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998, 56:317-333.
21. Han B., Jaurequi J., Tang B.W., Nimni M.E. Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrics. J Biomed Mater Res A 2003, 65:118-124.
22. Kim S., Nimni M.E., Yang Z., Han B. Chitosan/gelatin-based films crosslinked by proanthocyanidin. J Biomed Mater Res B 2005, 75:442-450.
23. Zhai W., Chang J., Lin K., Wang J., Zhao Q., Sun X. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 2006, 27:3684-3690.
24. Bedran-Russo A.K.B., Pereira P.N.R., Duarte W.R., Drummond J.L., Yamauchi M. Application of crosslinkers to dentin collagen enhances the ultimate tensile strength. J Biomed Mater Res B 2007, 80:268-272.
25. Chen K.Y., Shyu P.C., Chen Y.S., Yao C.H. Novel bone substitute composed of oligomeric proanthocyanidins-crosslinked gelatin and tricalcium phosphate. Macro Biosci 2008, 8:942-950.
26. Chen K.Y., Shyu P.C., Dong G.C., Chen Y.S., Kuo W.W., Yao C.H. Reconstruction of calvarial defect using a tricalcium phosphate-oligomeric proanthocyanidins cross-linked gelatin composite. Biomaterials 2009, 30:1682-1688.
27. Wong R.W.K., Rabie A.B.M. Traditional Chinese medicines and bone formation-a review. J Oral Maxillofac Surg 2006, 64:828-837.
28. Yao C.H., Tsai C.C., Chen Y.S., Chang C.J., Liu B.S., Lin C.C., et al. Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin and Chi-Li-San as a bone substitute. Am J Chin Med 2002, 30:471-482.
29. Yao C.H., Tsai H.M., Chen Y.S., Liu B.S. Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin and Chinese medicine as a bone substitute. J Biomed Mater Res B 2005, 75:277-288.
30. Sun J.S., Lin C.Y., Dong G.C., Sheu S.Y., Lin F.H., Chen L.T., et al. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) on bone cell activities. Biomaterials 2002, 23:3377-3385.
31. Jeong J.C., Lee J.W., Yoon C.H., Lee Y.C., Chung K.H., Kim M.G., et al. Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T 3-E1 cells. J Ethnopharmacol 2005, 96:489-495.
32. Wang X.L., Wang N.L., Zhang Y., Gao H., Pang W.Y., Wong M.S., et al. Effects of eleven flavonoids from the osteoprotective fraction of Drynaria fortunei (Kunze) J. Sm. on osteoblastic proliferation using an osteoblast-like cell line. Chem Pharm Bull 2008, 56:46-51.
33. Dong G.C., Chen H.M., Yao C.H. A novel bone substitute composite composed of tricalcium phosphate, gelatin and Drynaria fortunei herbal extract. J Biomed Mater Res A 2008, 84:167-177.